tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Raghuram Selvaraju, 1018 are a BUY (93.48%), 68 are a HOLD (6.24%), 3 are a SELL (0.28%).
Analyst Raghuram Selvaraju, carries an average stock price target met ratio of 33.52% that have a potential upside of 52.47% achieved within 186 days. Previously, Raghuram Selvaraju worked at HC WAINWRIGHT.
Raghuram Selvaraju’s has documented 2,019 price targets and ratings displayed on 118 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on URGN, UroGen Pharma Ltd at 08-Jul-2025.
Analyst best performing recommendations are on EVOK (EVOKE PHARMA).
The best stock recommendation documented was for EVOK (EVOKE PHARMA) at 7/18/2016. The price target of $288 was fulfilled within 3 days with a profit of $128.16 (30.8%) receiving and performance score of 102.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$7
$-9.93 (-58.65%)
$20
3 months ago
(16-Apr-2025)
8/12 (66.67%)
$-2.11 (-23.16%)
55
Buy
1 years 29 days ago
(17-Jun-2024)
10/37 (27.03%)
$101 (102.02%)
298
Sell
1 years 7 months 27 days ago
(19-Nov-2023)
1/3 (33.33%)
$-0.8 (-0.99%)
300
Hold
$20
$3.07 (18.13%)
$60
1 years 8 months 22 days ago
(24-Oct-2023)
3/22 (13.64%)
$5.72 (40.06%)
40
Hold
$25
$8.07 (47.67%)
$40
1 years 11 months 28 days ago
(18-Jul-2023)
2/5 (40%)
$3.4 (15.74%)
215
Which stock is Raghuram Selvaraju is most bullish on?
Which stock is Raghuram Selvaraju is most reserved on?
What Year was the first public recommendation made by Raghuram Selvaraju?
